Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2023-10-19 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Intimation of loss of share certificate
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificates. It is addressed to the stock exchange and provides details about the lost certificates. The content is a regulatory notification about share certificate status, not a financial report, earnings release, or management discussion. It does not contain financial data or detailed report content but is a compliance announcement. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-10-19 English
Regulation 44 Voting results of 71st AGM along with Scrutiniser''s report - resubmitted with covering letter.
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed submission of voting results from the 71st Annual General Meeting (AGM) of Fermenta Biotech Limited held on September 29, 2023. It includes voting outcomes on various resolutions such as adoption of financial statements, dividend declaration, director appointment, remuneration of auditors, related party transactions, and transfer of special reserve. The document references Regulation 44 of SEBI Listing Obligations and Disclosure Requirements, which mandates disclosure of voting results. It also contains the scrutinizer's report on the voting process. The content is focused on the official announcement of voting results from the AGM, not the AGM materials themselves or the full annual report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is not a brief announcement or a certification, but a full voting result report.
2023-09-30 English
Regulation 44 voting results for 71st AGM along with scrutiniser''s report
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed report on the submission of voting results from the Annual General Meeting (AGM) of Fermenta Biotech Limited held on September 29, 2023. It includes voting outcomes on various resolutions such as adoption of financial statements, dividend declaration, director appointment, remuneration fixing, related party transactions, and transfer of special reserve. The document also contains the Scrutinizer's report on the remote e-voting, ballot, and e-voting process conducted as per regulatory requirements under SEBI and MCA circulars. The content focuses on the official results of shareholder votes at the AGM, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not the AGM presentation itself, nor is it an announcement of a report publication, but the actual voting results report. Therefore, the correct classification is DVA with high confidence.
2023-09-29 English
Outcome of 71st AGM and summary of proceedings
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed communication about the outcome and proceedings of the 71st Annual General Meeting (AGM) of Fermenta Biotech Limited held on September 29, 2023. It includes information on the appointment of a director, dividend declaration, summary of the AGM proceedings, voting details, and resolutions passed. The document references Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, which mandates disclosure of material events including AGM outcomes. The content is not the full Annual Report but a summary and official announcement of the AGM proceedings and voting results. It does not contain full financial statements or detailed financial analysis but focuses on the meeting's conduct and decisions. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (9176 characters) supports it being a detailed announcement rather than a brief notice or a full report.
2023-09-29 English
Declaration of voting results along with Scrutiniser''s report for 71st AGM held on 29th September 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed declaration of voting results from the 71st Annual General Meeting (AGM) of Fermenta Biotech Limited held on September 29, 2023. It includes the results of remote e-voting, ballot forms, and e-voting at the AGM on various resolutions such as adoption of financial statements, dividend declaration, director appointment, auditor remuneration, related party transactions, and transfer of special reserve. The document references compliance with SEBI regulations and Companies Act provisions related to voting. It is not the AGM presentation or materials but the official declaration of voting results. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is not a brief announcement or a report publication notice, but the actual voting results declaration.
2023-09-29 English
Trading Window shall be closed from October 1, 2023 till 48 hours after declaration of financial results for quarter and half year ended September 30, 2023.
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window pursuant to SEBI regulations and company code of conduct. It informs about the trading restrictions around the announcement of quarterly and half-yearly financial results but does not contain any financial data or results itself. It is a regulatory announcement related to insider trading compliance and trading restrictions, not a financial report or earnings release. The document length is short (2473 characters) and it serves as a formal notification to the stock exchange. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2023-09-28 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.